Related Experiment Video
Updated: Jun 27, 2026

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
First Pediatric Lung Transplant Using the Paragonix BAROguard Preservation System
Yuriy Stukov1,2, Jeffrey P Jacobs1,2, Mark S Bleiweis1,2
1Division of Thoracic Surgery, Department of Surgery, University of Florida, Gainesville, Florida, USA.
Background:
Advances in donor organ preservation can potentially improve pediatric lung transplant outcomes. The ISHLT recommends that organ temperatures remain between 4°C and 6°C and that inflation pressures remain between 10 and 15 cm H2O during organ preservation. During traditional ice storage, temperature and inflation pressures rapidly fall below these suggested ranges. A recently developed preservation device, the Paragonix BAROguard Donor Lung Preservation System (BG) provides precise hypothermic and barometric control, ensuring that lung inflation pressure and tissue temperatures remain stable and within the ISHLT recommended range for the duration of storage. Here, we report the first clinical use of BG in a pediatric lung transplant case.
Methods:
A lung transplant was performed on a high-risk pediatric recipient after lung preservation using the BG system. We evaluated the recipient for 187 days posttransplant during hospitalization.
Results:
Despite multiple significant risk factors, including neuroblastoma and hemolytic uremic syndrome complicated by thrombotic microangiopathy resulting in persistent coughing, shortness of breath, and poor oral intake, the lung transplant was successful, and the patient was discharged after 187 days.
Conclusions:
The BG system can be safely utilized in pediatric lung transplantation, and BG preservation can be safely implemented in high-risk cases with poor clinical prognosis.
More Related Videos
09:31Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
Published on: February 14, 2022
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Kidney Transplant I: Introduction
Respiratory Syncytial Virus Disease